89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan
94 percent probability that intervention was cost-effective seen at a willingness-to-pay threshold of $28,000
Cesarean delivery accounts for highest proportion of MMEs dispensed after surgery among individuals aged 18 to 44 years
Positive and negative predictive values exceeded 95 percent for multitask large language model
Evidence seen for dose-response association, with 33 percent increased risk for one-unit lower cognitive function
Improvement in two-year progression-free survival seen with PGT versus standard of care or targeted agents not guided by molecular findings
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Lower rate of disease-free survival and overall survival seen for minimally invasive versus open hysterectomy
Responses more frequent in initiators than noninitiators, but 40 to 50 percent of initiators did not meet response criteria
Tailored recommendations presented to maximize survival and minimize side effects
Individuals with consistently high loneliness patterns over time had significantly higher incident stroke risk
14 percent of patients with early rheumatoid arthritis had mono-, oligo-arthritis and PGA ≥50